Shenzhen Hepalink Pharmaceutical Group Co., Ltd.(SHEZF)

Research Snapshot

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is a Healthcare stock with a market cap of $13.56B and listed on OTC. The stock last traded around $0.47 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +3.8%, EPS growth of -45.5%, a dividend yield of 2.3%. What stands out right now is revenue +3.8%, EPS -45.5%, free cash flow -20.1% with operating margin 12.3% and ROIC 3.8%. The dividend is present but secondary, with a yield around 2.3%. Valuation already assumes a fairly strong business story at P/E 41.9 and price/sales 2.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SHEZF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.